U.S. federal trademark · Serial No. 97640497
Peptide based tumor targeting technology, namely, a synthetic peptide attached via a self immolating chemical linker to an active pharmaceutical drug that specifically delivers active pharmaceutical drugs into the tumor cells while sparing normal tissues utilizing the low pH conditions of the tumor micro environment
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.